Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPM1B | O75688 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.33 |
| ▸ | MIF | P14174 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10946127 | 0.88 | CHRM2 (0.40) | PPM1BPTPN1PPP1CCALDH1A1MAPT | |
| SCHEMBL16570723 | 0.86 | PPM1B (0.47) | PPM1BPTPN1PPP1CCALDH1A1MAPT | |
| SCHEMBL69736 | 0.86 | PPM1B (0.47) | PPM1BPTPN1PPP1CCALDH1A1MAPT | |
| SCHEMBL8013452 | 0.78 | PPM1B (0.50) | PPM1BPTPN1PPP1CCALDH1A1MAPT | |
| SCHEMBL21987133 | 0.78 | PPM1B (0.50) | PPM1BPTPN1PPP1CCALDH1A1MAPT | |
| SCHEMBL23797762 | 0.78 | PPM1B (0.46) | PPM1BPTPN1PPP1CCALDH1A1MAPT | |
| SCHEMBL19088424 | 0.78 | MAPT (0.49) | ALDH1A1MAPTTSHRKDM4E | |
| SCHEMBL12899466 | 0.78 | PPM1B (0.46) | PPM1BPTPN1PPP1CCALDH1A1MAPT | |
| SCHEMBL71007 | 0.77 | PPM1B (0.44) | PPM1BPTPN1PPP1CCCHRM2CHRM4 | |
| SCHEMBL27449810 | 0.77 | PPM1B (0.40) | PPM1BPTPN1PPP1CCALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025110206-A1 | PERFUME, PERFUME COMPOSITION, METHOD FOR PRODUCING PERFUME, AND COMPOUND | 三菱瓦斯化学株式会社 | 2025-05-30 | — | — | WO | claimed |
| WO-2025110206-A1 | PERFUME, PERFUME COMPOSITION, METHOD FOR PRODUCING PERFUME, AND COMPOUND | 三菱瓦斯化学株式会社 | 2025-05-30 | — | — | WO | disclosed |
| US-20170189434-A1 | NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND THEIR USES | METRO INTERNATIONAL BIOTECH, LLC | 2017-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170189434-A1 | NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND THEIR USES | NAMPT, NNT, NQO1 | PPM1B 2005/4885PTPN1 3416/4885PPP1CC 3016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.